Fig. 5. Mutations in the genes encoding the U2AF38 and U1-70K splicing factors are
dosage-sensitive maternal modifiers of Sxl splicing autoregulation.
(A) Synergistic genetic interactions between splicing factors leads to
female-lethality. In these assays females of the indicated maternal genotype
were mated to Sxl7BO/Y males and the resulting male and
female progeny scored. The viability of the female progeny, all of which are
heterozygous for Sxl (Sxl7B0/+), was assessed by
comparing the number of females recovered to the number of males recovered.
(B) Sxl splicing pattern in Sxl7B0/+ female
embryos. Splicing was assayed by an RT-PCR based assay, in which RNA was
isolated from a pool of embryos in which only the Sxl7B0/+
embryos carried the reporter construct. This pool of embryos was collected
from the experimental adult females crossed to males carrying an X-chromosome
which carries both Sxl7B0 and a copy of the Sxl
reporter construct described in Fig.
3E. Lanes 3-5: embryos were collected from
snfJ210/+ control mothers (lane 3);
snfJ210/+; U2af38
E18/+ mothers
(lane 4); and snfJ210/+; U1-70K1/+
mothers (lane 5). Controls include: lane 1, splicing of the reporter construct
in adult males; and lane 2, splicing of the reporter construct in adult
females.